cryptolepine has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bierer, DE; Bruening, RC; Carlson, TJ; Dubenko, LG; Fort, DM; Gerber, RE; Hector, RF; Imbach, PA; Jolad, SD; King, SR; Litvak, J; Lu, Q; Luo, J; Mendez, CD; Noamesi, BK; Reed, MJ; Waldeck, N; Zhang, P | 1 |
| Bierer, DE; Cooper, R; Dubenko, LG; Fort, DM; Garofalo, AW; Gerber, RE; Imbach, PA; Litvak, J; Lu, Q; Luo, J; Phuan, PW; Reaven, GM; Sloan, B; Zhang, P | 1 |
2 other study(ies) available for cryptolepine and Alloxan Diabetes
| Article | Year |
|---|---|
Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities.
Topics: 3T3 Cells; Adipose Tissue; Alkaloids; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Eating; Fructose; Glucose; Hypoglycemic Agents; In Vitro Techniques; Indole Alkaloids; Indoles; Male; Mice; Mice, Obese; Plant Extracts; Quinolines; Rats; Rats, Sprague-Dawley | 1998 |
Antihyperglycemic activities of cryptolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolenta.
Topics: 3T3 Cells; Adipose Tissue; Alkaloids; Animals; Biological Transport; Blood Glucose; Diabetes Mellitus, Experimental; Glucose; Hypoglycemic Agents; Indole Alkaloids; Indoles; Mice; Mice, Obese; Plants, Medicinal; Quinolines; Structure-Activity Relationship | 1998 |